The purpose of this study is to examine the feasibility of an intervention to prevent chronic diseases like diabetes, high blood pressure, and obesity in midlife and older Latino adults living with HIV. The investigators expect that the participant will be in this study for seven months. Participants will be interviewed and asked to take part in walking groups.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
18
At week 1 and week 8 participants will meet individually with Community Health Worker (CHW) for 30 minutes for a manualized social and physical activation session.
A CHW led 45 minute (10 minutes of stretching and warm up, followed by 30 minutes of walking with a 5 minute cool down) group walk session of six participants at a time done 3 times a week that utilized interval training that slowly gradually increases in intensity.
A CHW led pleasant event discussion, asking each participant to identify a pleasant event. This task is done in conjunction with the cool down of HOLA 2.
Jackson Memorial Mental Health Hospital
Miami, Florida, United States
Number of Eligible Participants Refusing to Participate.
Number of eligible participants refusing to participate.
Time frame: Baseline
Retention Rate
Retention rate will be reported as the number of participants completing the post-intervention assessment.
Time frame: Up to 3 months post intervention
Acceptability of Intervention
As measured by the total number of sessions attended by the participants as a whole.
Time frame: Up to week 16
Change in Cardiometabolic Risk as Measured by Waist Circumference
As measured by the number of inches around the participant's waist. A waist circumference of 102 centimetres (40 inches) or more in men is associated with health problems such as type 2 diabetes, heart disease and high blood pressure.
Time frame: Baseline, 7 months post intervention
Change in Psychosocial Functioning as Measured by Depression Severity Scale
As measured by a 20-item Center for Epidemiologic Studies Depression (CES-D) scale. The possible range of scores are 0 to 60 with the higher scores indicating the presence of more symptomatology.
Time frame: Baseline, Month 4, Month 7
Change in Health-related Quality of Life as Measured by the Short Form Health Survey (SF-12)
The SF-12v2 is a measure of health related quality of life and provides 2 scores 1) Mental Component Summary Score (MCS) and 2) Physical Component Summary Score (PCS). MCS scores range from 0 to 100, higher scores indicate better mental health related quality of life.
Time frame: Baseline, Month 4, Month 7
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
One booster walking session twice a month for three months post intervention for reinforcement.
Change in Psychosocial Functioning as Measured by the Patient Health Questionnaire (PHQ-9)
severity of depression will be measured by the 9-item PHQ-9. Scores range from 0 to 27. With scores of 1-4 indicating minimal depression and scores of 20-27 indicating severe depression.
Time frame: Baseline, Month 4, Month 7
Change in Psychosocial Functioning as Measured by the Severity of Anxiety Using the Generalized Anxiety Disorder Scale
The 7-item Generalized Anxiety Disorder (GAD-7) scale will be used to measure the severity of anxiety. The scores range from 0 to 21 with scores of 0 to 5 indicating mild anxiety and scores of 15-21 indicating severe anxiety.
Time frame: Baseline, Month 4, Month 7
Change in Psychosocial Functioning as Measured by the Severity of Anxiety Using the Perceived Stress Scale
The 14 item Healthy Families Program Perceived Stress Scale will be used to measure the severity of anxiety. PSS scores can range from 0 to 40 with higher scores indicated higher perception of stress.
Time frame: Baseline, Month 4, Month 7
Change in Psychosocial Functioning as Measured by the Social Support Received
The 12 item Multidimensional Scale of Perceived Social support. After calculating the mean score across the categories a mean scale support score from 1 to 2.9 would indicate low support, whereas a mean score of 5.1 to 7 would indicate high support.
Time frame: Baseline, Month 4, Month 7
Change in Lipid Profile as Measured by Total Cholesterol, HDL-C, LDL-C, Triglycerides
A total cholesterol value of less than 200 mg/dL (5.18 mmol/L) is desirable and 240 mg/dL (6.22 mmol/L) or higher is high. Average HDL-C level is 40-50 mg/dL (1.0-1.3 mmol/L) for men. Low HDL-C level, increased risk, is less than 40 mg/dL (1.0 mmol/L). Optimal LDL-C levels are less than 100 mg/d while high levels are 160-189 mg/dL (4.15-4.90 mmol/L). Desirable triglyceride levels are less than 150 mg/dL (1.70 mmol/L) while high levels are considered 200-499 mg/dL (2.3-5.6 mmol/L).
Time frame: Baseline, Month 4, Month 7
Change in Hypertension as Measured by Systolic and Diastolic Blood Pressure.
Normal systolic and diastolic pressure is less than 120 mmHg and 80mmHg, respectively. High systolic and diastolic pressure is 140 mmHg or higher and 90 mmHg or higher, respectively.
Time frame: Baseline, Month 4, Month 7
Change in Glucose as Measured by Glycated Hemoglobin (Hba1c)
The normal range for the hemoglobin A1c level is between 4% and 5.6%. Hemoglobin A1c levels between 5.7% and 6.4% mean a higher chance of getting diabetes. Levels of 6.5% or higher mean diabetes.
Time frame: Baseline, Month 4, Month 7